ACUTE LEUKEMIA
Clinical trials for ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may reduce transplant complications in blood cancer patients
Disease control CompletedThis study tested whether adding the drug itacitinib to standard medications (tacrolimus and sirolimus) could help prevent graft-versus-host disease (GVHD) in 59 people with blood cancers like leukemia or myelodysplastic syndrome who received a donor stem cell transplant. GVHD oc…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
New drug combo aims to prevent transplant complications in blood cancer patients
Disease control CompletedThis study tested whether adding a drug called VIC-1911 to standard medications can prevent graft-versus-host disease (GVHD) and cancer relapse after a stem cell transplant. Sixteen adults with blood cancers like leukemia or lymphoma took part. The goal was to find the best dose …
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Expanded cord blood cells show promise in speeding recovery for blood cancer patients
Disease control CompletedThis study tested a new cord blood product called NiCord, which is grown in a lab to have more stem cells, against standard cord blood transplants for people with blood cancers like leukemia and lymphoma. The goal was to see if NiCord helps the body rebuild its blood and immune s…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Cancer drug vidaza tested as heart treatment – but only one patient joined
Disease control CompletedThis study looked at whether Vidaza, a drug used for acute leukemia, could also help treat atrial fibrillation (an irregular heartbeat). The idea was that Vidaza might reverse certain DNA changes that lower the activity of a gene important for heart function. Only one person took…
Matched conditions: ACUTE LEUKEMIA
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Could a drug make stem cell transplants safer and more effective?
Disease control CompletedThis study tested a drug called palifermin in 34 adults with blood cancers who received stem cell transplants from unrelated donors. The goal was to see if palifermin could reduce severe chronic graft-versus-host disease (GVHD), a serious complication where donor cells attack the…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
Beauty care eases anxiety for isolated blood cancer patients
Symptom relief CompletedThis study looked at whether aesthetic therapy (like beauty and relaxation sessions) can help reduce anxiety and improve quality of life for patients with acute leukemia or those who had a stem cell transplant. These patients are isolated in a protected hospital area for at least…
Matched conditions: ACUTE LEUKEMIA
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Leukemia clotting study reveals hidden blood changes
Knowledge-focused CompletedThis study looked at blood clotting markers in 60 people with acute leukemia (30 with ALL and 30 with AML) and compared them to 30 healthy volunteers. The goal was to see if these markers are different in leukemia patients. No treatment was given—only blood tests and medical exam…
Matched conditions: ACUTE LEUKEMIA
Sponsor: Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
650 blood cancer patients help scientists predict disease outcomes
Knowledge-focused CompletedThis study looked at 650 adults with acute leukemia, myelodysplastic syndromes, or myeloproliferative disorders. Researchers collected blood, bone marrow, skin, and cheek cell samples to find genetic and other markers that could predict how the disease behaves. The goal was to be…
Matched conditions: ACUTE LEUKEMIA
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC